You are here: Industry Insights > Development

News List

Innovent, Hutchison MediPharma in Drug Combo Collaboration contractpharma
December 03, 2018
Innovent Biologics, Inc. a China-based biopharmaceutical company has entered into a global collaboration agreement with Hutchison China MediTech to evaluate the safety and tolerability of Innovent's
Aji Bio-Pharma Introduces New ADC Mfg. Technology contractpharma
November 30, 2018
Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP.
MedPharm Appoints President & CEO contractpharma
November 30, 2018
Mr. Ciolfi is charged with driving MedPharm’s growth further downstream into commercial manfacturing and opening up additional markets based on the company’s unique performance modelling, formulation development
Marken, RareChannels Announce Collaboration contractpharma
November 27, 2018
Marken announced a new collaboration with RareChannels, a global web-based reference which allows manufactures of rare disease therapies and their affiliates to find customized logistic solutions.
Alvotech and Fuji Pharma Enter Biosimilars Tie-up contractpharma
November 27, 2018
Alvotech and Fuji Pharma are entering into an exclusive partnership for the commercialization by Fuji Pharma of Alvotech’s biosimilar portfolio in Japan.
Anchiano Therapeutics Names CMO contractpharma
November 27, 2018
David Kerstein, M.D., has been named chief medical officer of Anchiano Therapeutics, a clinical-stage biopharma company focused on novel therapies to treat cancer.
Two Senior Business Development Executives Join Life Biosciences americanpharmaceuticalreview
November 19, 2018
Sree Kant and Michael Ringel, JD, PhD, have been appointed to senior business development positions, according to an ann
'Big data' analysis links herpes virus to Alzheimer's development fiercebiotech
June 25, 2018
The idea that viruses might play a role in Alzheimer's disease is decades old but has never been definitively proven.
Pfizer eyes AI-powered drug discovery and development software newsnow
May 14, 2018
Its collaboration with Cambridge, Massachusetts-based XtalPi will see the firms work on molecular modelling software that can be applied to drug-like small molecules.
DiaSorin and Tecan to collaborate in new platform development europeanpharmaceuticalreview
June 30, 2017
DiaSorin and Tecan Group have announced that they have agreed to collaborate in a development under which DiaSorin will make use of Tecan’s Fluent® Laboratory Automation Solution as its nucleic acid extraction platform…

Previous page 1 2 3 4 5 6 Next page